SCHEMBL14812604

SCHEMBL14812604

COC(=O)Oc1ccc(C(=O)CBr)c(OC(=O)OC)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ELANE P08246 3/20 0.43
▸ GSK3B P49841 1/20 0.42
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ PKM P14618 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11015630 0.81 KDM4E (0.66) HPGDSKDM4EELANEGSK3BHPGD
SCHEMBL14812412 0.81 KDM4E (0.51) KDM4EELANEHPGDHSD17B10SMN1; SMN2
SCHEMBL29799615 0.78 SMN1; SMN2 (0.61) HPGDSKDM4EGSK3BHPGDSMN1; SMN2
SCHEMBL624930 0.78 SMN1; SMN2 (0.61) HPGDSKDM4EGSK3BHPGDSMN1; SMN2
SCHEMBL7398995 0.75 ALDH1A1 (0.53) HPGDSKDM4EGSK3BHSD17B10SMN1; SMN2
SCHEMBL5052478 0.74 KDM4E (0.56) HPGDSKDM4EGSK3BHPGDHSD17B10
SCHEMBL5057119 0.73 KDM4E (0.69) HPGDSKDM4EGSK3BHPGDHSD17B10
SCHEMBL7334423 0.72 RXFP1 (0.49) HPGDSGSK3BSMN1; SMN2LMNAHTT
SCHEMBL28830235 0.72 CA12 (0.57) KDM4EHPGDSMN1; SMN2TP53LMNA
SCHEMBL24263499 0.71 HPGDS (0.51) HPGDSKDM4EGSK3BHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2969027-B1 COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND FRAGRANCES BEIERSDORF AG (DE) 2020-10-14 — — EP disclosed
EP-3176156-B1 ALKYLAMIDOTHIAZOLES, COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF UNWANTED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2019-06-12 — — EP disclosed
EP-2968100-B1 COMBINATION OF ALKYLAMIDOTHIAZOLES AND PRESERVATIVES BEIERSDORF AG (DE) 2019-04-10 — — EP disclosed
US-10245252-B2 Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin BEIERSDORF AG (DE) 2019-04-02 — — US disclosed
EP-2969028-B1 COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND UV FILTER SUBSTANCES BEIERSDORF AG (DE) 2018-05-09 — — EP disclosed
EP-3176156-A1 ALKYLAMIDOTHIAZOLES, COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF UNWANTED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2017-06-07 — — EP disclosed
US-9610234-B2 Combinations of alkylamidothiazoles and preservatives BEIERSDORF AG (DE) 2017-04-04 — — US disclosed
EP-2758381-B1 ALKYLAMIDOTHIAZOLES, COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF UNWANTED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2017-03-01 — — EP disclosed
US-9533963-B2 Alkylamidothiazoles, cosmetic or dermatological preparations containing said alkylamidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin BEIERSDORF AG (DE) 2017-01-03 — — US disclosed
US-20160324832-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN BEIERSDORF AG (DE) 2016-11-10 — — US disclosed
WO-2014139741-A1 COMBINATIONS OF ALKYLAMIDOTHIAZOLES AND CYCLODEXTRINS BEIERSDORF AG (DE) 2014-09-18 — — WO disclosed
WO-2014139758-A1 COMPOSITIONS CONSISTING OF ALKYLAMIDOTHIAZOLES AND AROMATIC SUBSTANCES BEIERSDORF AG (DE) 2014-09-18 — — WO disclosed
WO-2014139757-A1 COMBINATIONS OF ALKYLAMIDOTHIAZOLES AND PRESERVATIVES BEIERSDORF AG (DE) 2014-09-18 — — WO disclosed
EP-2758381-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 — — EP disclosed
EP-2758383-A1 AROMATIC AMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID AROMATIC AMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 — — EP disclosed
EP-2758382-A1 HETEROCYCLOCARBONYLAMINOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID HETEROCYCLOCARBONYLAMINOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 — — EP disclosed
US-20140121250-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2014-05-01 — — US disclosed
WO-2013041537-A1 HETEROCYCLOCARBONYLAMINOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID HETEROCYCLOCARBONYLAMINOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 — — WO disclosed
WO-2013041535-A1 AROMATIC AMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID AROMATIC AMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 — — WO disclosed
WO-2013041526-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140121250-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN TYR, PAH, NAT1 HPGDS 3483/4885KDM4E 2444/4885ELANE 2401/4885
US-10245252-B2 Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin CUTA, TYR, AADAC HPGDS 2704/4885KDM4E 4027/4885ELANE 48/4885
US-20160324832-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN CUTA, TYR, AADAC HPGDS 2704/4885KDM4E 4027/4885ELANE 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback